Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03915678
Title Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors (AGADIR)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Bergonie
Indications

nasopharynx carcinoma

urinary bladder cancer

head and neck cancer

sarcoma

pancreatic cancer

triple-receptor negative breast cancer

lung non-small cell carcinoma

cervical cancer

Kaposi's sarcoma

Therapies

Atezolizumab + BDB001

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.